• Explore /
  • Poster
  • / First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5- fluorouracil (DCF) plus panitumumab (P) in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction (GEJ): A phase II multicenter trial.

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5- fluorouracil (DCF) plus panitumumab (P) in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction (GEJ): A phase II multicenter trial.

Abstract Poster

Authors

null

Gianluca Tomasello

Istituti Ospitalieri di Cremona, Cremona, Italy

Gianluca Tomasello , Wanda Liguigli , Laura Toppo , Rodolfo Mattioli , Federica Negri , Alessandra Curti , Margherita Ratti , Rossana Poli , Silvia Lazzarelli , Fabiana Gerevini , Chiara Colombi , Mario Martinotti , Massimo Rovatti , Lucio Olivetti , Rodolfo Passalacqua

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

2009-016962-10

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 146)

DOI

10.1200/jco.2015.33.3_suppl.146

Abstract #

146

Poster Bd #

C44

Abstract Disclosures

Similar Posters

First Author: Takashi Ura

First Author: Ralf Hofheinz

First Author: Thierry Alcindor

First Author: Jin Won Kim